Anticoagulant Reversal Drugs Market is expected to reach US$ 2.35 Bn. at a CAGR of 14.3 % during the forecast period 2029.Anticoagulant Reversal Drugs Market Overview:
In specific instances, such as unanticipated surgery, anticoagulant overdose, and uncontrolled bleeding, anticoagulant reversal drugs are required to reverse the anticoagulant effect. It also protects those suffering from blood clots from dangerous diseases including strokes and heart attacks.To know about the Research Methodology :- Request Free Sample Report
Anticoagulant Reversal Drugs Market Dynamics:
Rising prevalence of bleeding disorders such as haemophilia is the major factor driving the market growth. Anticoagulant reversal medications are used to treat venous thromboembolism, atrial fibrillation (AF), mechanical valve replacement, and other coagulation disorders like antiphospholipid antibody syndrome. The market for anticoagulant reversal drugs is growing due to reasons such as the rising prevalence of atrial fibrillation (AFib). Von Willebrand Disease (VWD) is a common kind that affects one out of every 100 persons. Such bleeding diseases disrupt blood coagulation, resulting in profuse bleeding both inside and outside the body. Individuals may die as a result of excessive bleeding, which needs the administration of anticoagulant reversal medicines. Other factors, such as the approval of successful treatments in recent years and the presence of novel drugs in the pipeline, are crucial in moving the industry to the next level. Inadvertently, the rise in the number of ambulatory surgical operations, combined with an increasing demand for minimally invasive surgeries, produces a highly favorable environment for the growth of the anticoagulant reversal medications market. The United States Food and Drug Administration (FDA) approved Andexxa by Portola Pharmaceuticals as the first factor Xa inhibitor antidote in May 2018. The Andexxa was planned to be launched in early June under an Early Supply Program with Generation 1 product. However, in August 2019, the company announced the first sale of Andexxa in Europe, owing to a higher number of patients taking Factor Xa inhibitors in Europe than in the United States. Andexxa has been designated as a breakthrough treatment by the FDA as well as an orphan drug in the United States. Some drugs, including blood thinners such as heparin, aspirin, and warfarin, can cause bleeding disorders. The type of anticoagulant agent used affects the risk of bleeding. The National Centre for Biotechnology Information (NCBI) states that the frequency of bleeding in warfarin patients is projected to be 15-20% per year. The report has profiled seventeen key players in the market from different regions. However, report has considered all market leaders, followers and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed and report has come up with recommendations for future hot spot in APAC region.Anticoagulant Reversal Drugs Market Segment Analysis:
The Global Anticoagulant Reversal Drugs Market is segmented on the basis of Drug Type and Distribution Channel. Based on Drug Type, the coagulation factor segment is expected to hold dominant market share during forecast period. Coagulation factors are blood proteins that regulate bleeding and are made up of a variety of coagulation factors. In most COVID-19 infected patients, coagulopathy of varying severity was observed, which was characterized by elevated D-dimer levels and fibrinogen or fibrin degradation products, as well as irregular measurements in the prothrombin time, acute partial thromboplastin time, and platelet counts, according to a study published in the Lancet in 2022. Hence, COVID-19 is expected to impact the segment growth positively during the pandemic. Due to the approval and launch of andexanet alfa in the markets, the andexanet alfa segment is expected to grow at a faster pace during the forecast period. The Centers for Medicare & Medicaid Services (CMS) assigned Andexxa a permanent J-code in April 2021, easing reimbursement in hospital outpatient environments.Anticoagulant Reversal Drugs Market Regional Insights:
North America accounted for significant share in 2022. North America is projected to retain its lead over the forecast period. The United States held the largest share xx% of the North American economy. High healthcare expenditure and favourable healthcare reimbursement policies for expensive drugs are two key factors driving its development. Furthermore, the regional demand is being driven by the simple availability of these reversal drugs in emergency situations. Asia Pacific is expected to witness faster growth during forecast period. The emergence of a large target population in emerging countries like China and India has aided regional market growth significantly. Furthermore, rising awareness and the rising occurrence of bleeding disorders in the area are driving up demand for anticoagulant reversal drugs. The report also helps in understanding Global Anticoagulant Reversal Drugs Market dynamics, structure by analyzing the market segments and project the Global Anticoagulant Reversal Drugs Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Anticoagulant Reversal Drugs Market make the report investor’s guide.Anticoagulant Reversal Drugs Market Scope: Inquire before buying
Anticoagulant Reversal Drugs Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2018 to 2022 Market Size in 2022: US $ 0.92 Bn. Forecast Period 2023 to 2029 CAGR: 14.3% Market Size in 2029: US $ 2.35 Bn. Segments Covered: by Product Prothrombin Complex Concentrates Coagulation Factors Phytonadione Antexanet Alfa Idarucizumab by Type Hospital Pharmacy Online Pharmacy Retail Pharmacy Anticoagulant Reversal Drugs Market, By Region:
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Anticoagulant Reversal Drugs Market, Key Players:
1. Bausch Health Companies, Inc. 2. Pfizer, Inc. 3. Fresenius Kabi AG 4. Amneal Pharmaceuticals, Inc. 5. Boehringer Ingelheim GmbH 6. CSL Limited 7. Octapharma AG 8. Portola Pharmaceuticals, Inc. 9. Perosphere Pharmaceuticals, Inc. 10. Dr. Reddy's Laboratories 11. AMAG Pharmaceuticals, Inc. 12. SGPharma Pvt. Ltd. 13. Alps Pharmaceutical Ind. Co., Ltd. 14. Zydus Cadila 15. FERRING PHARMACEUTICALS 16. Grifols, S.A. 17. Shanghai RAAS Blood Products Co Frequently Asked Questions: 1. Which region has the largest share in Global Anticoagulant Reversal Drugs Market? Ans: Asia Pacific region holds the highest share in 2022. 2. What is the growth rate of Global Anticoagulant Reversal Drugs Market? Ans: The Global Anticoagulant Reversal Drugs Market is growing at a CAGR of 14.3% during forecasting period 2023-2029. 3. What is scope of the Global Anticoagulant Reversal Drugs Market report? Ans: Global Anticoagulant Reversal Drugs Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. What is the study period of this market? Ans: The Global Anticoagulant Reversal Drugs Market is studied from 2022 to 2029.
1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Anticoagulant Reversal Drugs Market Size, by Market Value (US$ Mn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2022 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Anticoagulant Reversal Drugs Market 3.4. Geographical Snapshot of the Anticoagulant Reversal Drugs Market, By Manufacturer share 4. Global Anticoagulant Reversal Drugs Market Overview, 2022-2029 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Products 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Anticoagulant Reversal Drugs Market 5. Supply Side and Demand Side Indicators 6. Global Anticoagulant Reversal Drugs Market Analysis and Forecast, 2022-2029 6.1. Global Anticoagulant Reversal Drugs Market Size & Y-o-Y Growth Analysis. 7. Global Anticoagulant Reversal Drugs Market Analysis and Forecasts, 2022-2029 7.1. Market Size (Value) Estimates & Forecast By Drug Type, 2022-2029 7.1.1. Prothrombin Complex Concentrates 7.1.2. Coagulation Factors 7.1.3. Phytonadione 7.1.4. Andexanet Alfa 7.1.5. Idarucizumab 7.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 7.2.1. Hospital Pharmacy 7.2.2. Online Pharmacy 7.2.3. Retail Pharmacy 8. Global Anticoagulant Reversal Drugs Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2022-2029 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Anticoagulant Reversal Drugs Market Analysis and Forecasts, 2022-2029 9.1. Market Size (Value) Estimates & Forecast By Drug Type, 2022-2029 9.1.1. Prothrombin Complex Concentrates 9.1.2. Coagulation Factors 9.1.3. Phytonadione 9.1.4. Andexanet Alfa 9.1.5. Idarucizumab 9.2. Market Size (Value) Estimates & Forecast By Distribution Channel , 2022-2029 9.2.1. Hospital Pharmacy 9.2.2. Online Pharmacy 9.2.3. Retail Pharmacy 10. North America Anticoagulant Reversal Drugs Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Anticoagulant Reversal Drugs Market Analysis and Forecasts, 2022-2029 11.1. Market Size (Value) Estimates & Forecast By Drug Type, 2022-2029 11.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 12. Canada Anticoagulant Reversal Drugs Market Analysis and Forecasts, 2022-2029 12.1. Market Size (Value) Estimates & Forecast By Drug Type, 2022-2029 12.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 13. Mexico Anticoagulant Reversal Drugs Market Analysis and Forecasts, 2022-2029 13.1. Market Size (Value) Estimates & Forecast By Drug Type, 2022-2029 13.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 14. Europe Anticoagulant Reversal Drugs Market Analysis and Forecasts, 2022-2029 14.1. Market Size (Value) Estimates & Forecast By Drug Type, 2022-2029 14.2. Market Size (Value) Estimates & Forecast By Distribution Channel , 2022-2029 15. Europe Anticoagulant Reversal Drugs Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K. Anticoagulant Reversal Drugs Market Analysis and Forecasts, 2022-2029 16.1. Market Size (Value) Estimates & Forecast By Drug Type, 2022-2029 16.2. Market Size (Value) Estimates & Forecast By Distribution Channel , 2022-2029 17. France Anticoagulant Reversal Drugs Market Analysis and Forecasts, 2022-2029 17.1. Market Size (Value) Estimates & Forecast By Drug Type, 2022-2029 17.2. Market Size (Value) Estimates & Forecast By Distribution Channel , 2022-2029 18. Germany Anticoagulant Reversal Drugs Market Analysis and Forecasts, 2022-2029 18.1. Market Size (Value) Estimates & Forecast By Drug Type, 2022-2029 18.2. Market Size (Value) Estimates & Forecast By Distribution Channel , 2022-2029 19. Italy Anticoagulant Reversal Drugs Market Analysis and Forecasts, 2022-2029 19.1. Market Size (Value) Estimates & Forecast By Drug Type, 2022-2029 19.2. Market Size (Value) Estimates & Forecast By Distribution Channel , 2022-2029 20. Spain Anticoagulant Reversal Drugs Market Analysis and Forecasts, 2022-2029 20.1. Market Size (Value) Estimates & Forecast By Drug Type, 2022-2029 20.2. Market Size (Value) Estimates & Forecast By Distribution Channel , 2022-2029 21. Sweden Anticoagulant Reversal Drugs Market Analysis and Forecasts, 2022-2029 21.1. Market Size (Value) Estimates & Forecast By Drug Type, 2022-2029 21.2. Market Size (Value) Estimates & Forecast By Distribution Channel , 2022-2029 22. CIS Countries Anticoagulant Reversal Drugs Market Analysis and Forecasts, 2022-2029 22.1. Market Size (Value) Estimates & Forecast By Drug Type, 2022-2029 22.2. Market Size (Value) Estimates & Forecast By Distribution Channel , 2022-2029 23. Rest of Europe Anticoagulant Reversal Drugs Market Analysis and Forecasts, 2022-2029 23.1. Market Size (Value) Estimates & Forecast By Drug Type, 2022-2029 23.2. Market Size (Value) Estimates & Forecast By Distribution Channel , 2022-2029 24. Asia Pacific Anticoagulant Reversal Drugs Market Analysis and Forecasts, 2022-2029 24.1. Market Size (Value) Estimates & Forecast By Drug Type, 2022-2029 24.2. Market Size (Value) Estimates & Forecast By Distribution Channel , 2022-2029 25. Asia Pacific Anticoagulant Reversal Drugs Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Anticoagulant Reversal Drugs Market Analysis and Forecasts, 2022-2029 26.1. Market Size (Value) Estimates & Forecast By Drug Type, 2022-2029 26.2. Market Size (Value) Estimates & Forecast By Distribution Channel , 2022-2029 27. India Anticoagulant Reversal Drugs Market Analysis and Forecasts, 2022-2029 27.1. Market Size (Value) Estimates & Forecast By Drug Type, 2022-2029 27.2. Market Size (Value) Estimates & Forecast By Distribution Channel , 2022-2029 28. Japan Anticoagulant Reversal Drugs Market Analysis and Forecasts, 2022-2029 28.1. Market Size (Value) Estimates & Forecast By Drug Type, 2022-2029 28.2. Market Size (Value) Estimates & Forecast By Distribution Channel , 2022-2029 29. South Korea Anticoagulant Reversal Drugs Market Analysis and Forecasts, 2022-2029 29.1. Market Size (Value) Estimates & Forecast By Drug Type, 2022-2029 29.2. Market Size (Value) Estimates & Forecast By Distribution Channel , 2022-2029 30. Australia Anticoagulant Reversal Drugs Market Analysis and Forecasts, 2022-2029 30.1. Market Size (Value) Estimates & Forecast By Drug Type, 2022-2029 30.2. Market Size (Value) Estimates & Forecast By Distribution Channel , 2022-2029 31. ASEAN Anticoagulant Reversal Drugs Market Analysis and Forecasts, 2022-2029 31.1. Market Size (Value) Estimates & Forecast By Drug Type, 2022-2029 31.2. Market Size (Value) Estimates & Forecast By Distribution Channel , 2022-2029 32. Rest of Asia Pacific Anticoagulant Reversal Drugs Market Analysis and Forecasts, 2022-2029 32.1. Market Size (Value) Estimates & Forecast By Drug Type, 2022-2029 32.2. Market Size (Value) Estimates & Forecast By Distribution Channel , 2022-2029 33. Middle East Africa Anticoagulant Reversal Drugs Market Analysis and Forecasts, 2022-2029 33.1. Market Size (Value) Estimates & Forecast By Drug Type, 2022-2029 33.2. Market Size (Value) Estimates & Forecast By Distribution Channel , 2022-2029 34. Middle East Africa Anticoagulant Reversal Drugs Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Anticoagulant Reversal Drugs Market Analysis and Forecasts, 2022-2029 35.1. Market Size (Value) Estimates & Forecast By Drug Type, 2022-2029 35.2. Market Size (Value) Estimates & Forecast By Distribution Channel , 2022-2029 36. GCC Countries Anticoagulant Reversal Drugs Market Analysis and Forecasts, 2022-2029 36.1. Market Size (Value) Estimates & Forecast By Drug Type, 2022-2029 36.2. Market Size (Value) Estimates & Forecast By Distribution Channel , 2022-2029 37. Egypt Anticoagulant Reversal Drugs Market Analysis and Forecasts, 2022-2029 37.1. Market Size (Value) Estimates & Forecast By Drug Type, 2022-2029 37.2. Market Size (Value) Estimates & Forecast By Distribution Channel , 2022-2029 38. Nigeria Anticoagulant Reversal Drugs Market Analysis and Forecasts, 2022-2029 38.1. Market Size (Value) Estimates & Forecast By Drug Type, 2022-2029 38.2. Market Size (Value) Estimates & Forecast By Distribution Channel , 2022-2029 39. Rest of ME&A Anticoagulant Reversal Drugs Market Analysis and Forecasts, 2022-2029 39.1. Market Size (Value) Estimates & Forecast By Drug Type, 2022-2029 39.2. Market Size (Value) Estimates & Forecast By Distribution Channel , 2022-2029 40. South America Anticoagulant Reversal Drugs Market Analysis and Forecasts, 2022-2029 40.1. Market Size (Value) Estimates & Forecast By Drug Type, 2022-2029 40.2. Market Size (Value) Estimates & Forecast By Distribution Channel , 2022-2029 41. South America Anticoagulant Reversal Drugs Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Anticoagulant Reversal Drugs Market Analysis and Forecasts, 2022-2029 42.1. Market Size (Value) Estimates & Forecast By Drug Type, 2022-2029 42.2. Market Size (Value) Estimates & Forecast By Distribution Channel , 2022-2029 43. Argentina Anticoagulant Reversal Drugs Market Analysis and Forecasts, 2022-2029 43.1. Market Size (Value) Estimates & Forecast By Drug Type, 2022-2029 43.2. Market Size (Value) Estimates & Forecast By Distribution Channel , 2022-2029 44. Rest of South America Anticoagulant Reversal Drugs Market Analysis and Forecasts, 2022-2029 44.1. Market Size (Value) Estimates & Forecast By Drug Type, 2022-2029 44.2. Market Size (Value) Estimates & Forecast By Distribution Channel , 2022-2029 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global Anticoagulant Reversal Drugs Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Applications and R&D Investment 45.2.2. New Product Launches and Product Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 45.3. Company Profile : Key Players 45.3.1. Bausch Health Companies, Inc. 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Product Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Developments 45.3.2. Pfizer, Inc. 45.3.3. Fresenius Kabi AG 45.3.4. Amneal Pharmaceuticals, Inc. 45.3.5. Boehringer Ingelheim GmbH 45.3.6. CSL Limited 45.3.7. Octapharma AG 45.3.8. Portola Pharmaceuticals, Inc. 45.3.9. Perosphere Pharmaceuticals, Inc. 45.3.10. Dr. Reddy's Laboratories 45.3.11. AMAG Pharmaceuticals, Inc. 45.3.12. SGPharma Pvt. Ltd. 45.3.13. Alps Pharmaceutical Ind. Co., Ltd. 45.3.14. Zydus Cadila 45.3.15. FERRING PHARMACEUTICALS 45.3.16. Grifols, S.A. 45.3.17. Shanghai RAAS Blood Products Co 46. Primary Key Insights